Tata Consumer Products Ltd (TCPL) is in advanced negotiations to acquire Danone SA’s India nutraceuticals and specialized nutrition business, a potential move that could significantly strengthen its foothold in the booming health and protein market, according to people familiar with the discussions.
Talks, ongoing for several months, have accelerated in recent weeks as both sides inch closer to settling valuation terms. If finalized, the acquisition would mark TCPL’s most aggressive push yet into value-added nutrition—placing the maker of Tata Tea and Tata Salt in direct competition with global heavyweights like Nestlé and Abbott.
The French major currently generates most of its India revenue from the nutrition portfolio it acquired from Wockhardt for ₹1,576 crore, which includes marquee brands such as Farex, Dexolac and Protinex—key players in infant and adult nutrition. These categories have outpaced the broader packaged foods market, propelled by rising consumer focus on preventive health, protein consumption and immunity-boosting products.
TCPL’s Expanding Health & Wellness Play
Over the past few years, TCPL has aggressively diversified beyond beverages and staples, building a wellness-led portfolio through strategic acquisitions such as Soulfull, Capital Foods and Organic India. It has also entered the plant-based meat category with Tata Simply Better, offering nuggets and burger patties.
This aligns with the broader post-pandemic surge in health-focused consumption. Protein, in particular, has emerged as the “hottest battleground,” with brands across FMCG accelerating entry into powders, fortified foods and plant-based alternatives.
Even dairy cooperative Amul expanded into protein supplements two years ago, while ITC launched plant-based protein snacks and introduced egg and milk-enriched biscuits. Nestlé India has also conducted test launches of plant-based products through partnerships with chains like Social and Boss Burger.
A Crowded and Highly Regulated Arena
Industry experts say the Danone acquisition could give Tata Consumer a significant edge with established brands and a loyal consumer base in nutrition. But the segment is not without challenges.
“Cracking the nutraceuticals and infant nutrition space won’t be easy,” said Abneesh Roy, executive director at Nuvama Institutional Equities. “While the Tata brand adds trust—especially in sensitive categories like infant nutrition—the segment is heavily regulated and dominated by stronger rivals like Nestlé.”
TCPL’s managing director Sunil D’Souza has consistently maintained a disciplined approach to acquisitions, stressing that he would “not overpay” or get swayed by inflated valuations. His “middle-class mindset,” as he describes it, has driven deals that fit long-term strategic priorities without premium overspend.
India: A High-Growth Nutrition Hub
With 23 million births each year and nearly 500 million Indians expected to turn 65 by 2030, the country represents one of the most important global markets for specialised nutrition. Rising incomes, urban demand for functional foods, and post-pandemic lifestyle shifts have created a robust growth runway for categories like infant formula, adult supplements and protein-rich foods.
Danone’s India journey has seen several pivots. After ending its biscuit partnership with Britannia in 2009, the company built its nutrition business largely through the 2012 Wockhardt acquisition. It briefly expanded into dairy beginning 2010 but exited the category in 2018 after failing to compete effectively with large domestic cooperatives such as Amul and Mother Dairy.
Today, its strategy is firmly anchored in nutrition—precisely the space TCPL is now seeking to dominate.
If the deal goes through, it could mark one of the most significant consolidations in India’s health and nutrition market, reshaping competitive dynamics and signalling the next big wave of growth for Tata Consumer Products.